drug2ways

drug2ways predicts potential drug candidates and mechanisms by reasoning over causal paths in multimodal causal large-scale biological networks to support drug discovery and drug repositioning.

Key Features:

• Causal Path Reasoning: Implements an efficient algorithm that reasons over causal paths in extensive biological networks to identify how a drug candidate might influence specific biological states associated with disease.
• Multimodal Causal Networks: Operates on multimodal causal networks to integrate diverse types of molecular interactions within large-scale biological networks.
• Network Topology Utilization: Leverages network topology to elucidate potential therapeutic targets and guide drug repositioning by revealing pathway-level relationships.
• Standard Network Format Support: Supports multiple standard network formats for input interoperability.
• Clinical Validation: Methodology has been validated using clinical trial data.

Scientific Applications:

• Single-target Drug Candidates: Identifies drugs that target a single biological entity for targeted therapeutic intervention.
• Polypharmacological Properties: Detects candidates with the ability to modulate multiple targets simultaneously for polypharmacological strategies.
• Combination Therapy Candidates: Facilitates identification of drug combinations that could be used in combination therapies to enhance treatment efficacy.
• Drug Repositioning: Guides drug repositioning efforts by mapping existing drugs onto disease-relevant causal pathways.
• Disease Characterization: Supports characterization of disease mechanisms by revealing causal molecular pathways underlying disease states.

Methodology:

Reasoning over causal paths in multimodal causal networks using an efficient algorithm that analyzes network topology in large-scale biological networks.